Literature DB >> 28004618

Organisation of services for managing ADHD.

D R Coghill1.   

Abstract

There is considerable variation in practice, both between and with different countries in the management of attention deficit hyperactivity disorder (ADHD). Whilst there is no one optimal model of service organisation there are general principles of care that can be introduced to reduce this variability. There are frequent debates and discussions about which professional group is best placed to manage ADHD at different points in the life cycle. Who delivers care is however less important than ensuring that training schemes provide adequate exposure, training and experience to both the core and non-core skills required to provide a comprehensive package of care. Most evidence-based guidelines recommend a multi-modal, multi-professional and multi-agency approach. Many also promote the use of both stepped care and shared care approaches for the management of ADHD. As most of those with ADHD continue to have ADHD-related problems into adulthood, it is important to consider how best to transition care into adulthood and think about who should deliver care to adults with ADHD. Young people with ADHD should generally be transferred to adult mental health services if they continue to have significant symptoms of ADHD or other coexisting conditions that require treatment. Unfortunately services for adults with ADHD remain relatively scarce across much of the world and some adult psychiatrists remain unsure of the diagnosis and uncertain about the appropriate use of ADHD medications in adults, but there is a strong case for increased services for adults. ADHD is on the one hand easy to treat; it is much more difficult to treat well. Although optimised care for ADHD requires routine measurement of outcomes, this often does not happen in routine clinical practice. Focusing on optimising symptoms and minimising adverse effects can significantly improve both short- and long-term outcomes.

Entities:  

Keywords:  ADHD; medication; outcomes; treatment

Mesh:

Year:  2016        PMID: 28004618      PMCID: PMC6998894          DOI: 10.1017/S2045796016000937

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  40 in total

1.  Editorial: Painting by numbers: using modern approaches to analyse and visualise clinical and research data.

Authors:  David Coghill
Journal:  J Child Psychol Psychiatry       Date:  2015-10       Impact factor: 8.982

Review 2.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

Review 3.  Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes.

Authors:  Nicoletta Adamo; Sarah Seth; David Coghill
Journal:  Expert Rev Clin Pharmacol       Date:  2015       Impact factor: 5.045

Review 4.  Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

Authors:  Samuele Cortese; Martin Holtmann; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Ralf W Dittmann; John Graham; Eric Taylor; Joseph Sergeant
Journal:  J Child Psychol Psychiatry       Date:  2013-01-07       Impact factor: 8.982

5.  Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome.

Authors:  Arthur Caye; Thiago Botter-Maio Rocha; Luciana Anselmi; Joseph Murray; Ana M B Menezes; Fernando C Barros; Helen Gonçalves; Fernando Wehrmeister; Christina M Jensen; Hans-Christoph Steinhausen; James M Swanson; Christian Kieling; Luis Augusto Rohde
Journal:  JAMA Psychiatry       Date:  2016-07-01       Impact factor: 21.596

Review 6.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

7.  Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.

Authors:  Laurel K Leslie; Jill Weckerly; Dena Plemmons; John Landsverk; Sarita Eastman
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

8.  Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study.

Authors:  Terrie E Moffitt; Renate Houts; Philip Asherson; Daniel W Belsky; David L Corcoran; Maggie Hammerle; HonaLee Harrington; Sean Hogan; Madeline H Meier; Guilherme V Polanczyk; Richie Poulton; Sandhya Ramrakha; Karen Sugden; Benjamin Williams; Luis Augusto Rohde; Avshalom Caspi
Journal:  Am J Psychiatry       Date:  2015-05-22       Impact factor: 18.112

9.  Mapping English GP prescribing data: a tool for monitoring health-service inequalities.

Authors:  Barry Rowlingson; Euan Lawson; Benjamin Taylor; Peter J Diggle
Journal:  BMJ Open       Date:  2013-01-03       Impact factor: 2.692

10.  Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls.

Authors:  David Coghill; Paul Hodgkins
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-06-09       Impact factor: 4.785

View more
  11 in total

1.  Attention-deficit/hyperactivity disorder (ADHD): from randomised controlled trials to evidence-based clinical services.

Authors:  S Cortese; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-09       Impact factor: 6.892

2.  Optimising treatment strategies for ADHD in adolescence to minimise 'lost in transition' to adulthood.

Authors:  J K Buitelaar
Journal:  Epidemiol Psychiatr Sci       Date:  2017-04-17       Impact factor: 6.892

3.  General practitioner-centred paediatric primary care reduces risk of hospitalisation for mental disorders in children and adolescents with ADHD: findings from a retrospective cohort study.

Authors:  Angelina Mueller; Olga A Sawicki; Moritz Philipp Günther; Anastasiya Glushan; Claudia Witte; Renate Klaaßen-Mielke; Ferdinand M Gerlach; Martin Beyer; Kateryna Karimova
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

4.  Transitional care for young adults with ADHD: transforming potential upheaval into smooth progression.

Authors:  Tamsin Ford
Journal:  Epidemiol Psychiatr Sci       Date:  2020-01-09       Impact factor: 6.892

5.  Mapping UK mental health services for adults with attention-deficit/hyperactivity disorder: national survey with comparison of reporting between three stakeholder groups.

Authors:  Anna Price; Astrid Janssens; Tamsin Newlove-Delgado; Helen Eke; Moli Paul; Kapil Sayal; Chris Hollis; Cornelius Ani; Susan Young; Susan Dunn-Morua; Philip Asherson; Stuart Logan; Tamsin Ford
Journal:  BJPsych Open       Date:  2020-07-29

Review 6.  ADHD prevalence estimates in Italian children and adolescents: a methodological issue.

Authors:  Laura Reale; Maurizio Bonati
Journal:  Ital J Pediatr       Date:  2018-09-05       Impact factor: 2.638

7.  Seven steps to mapping health service provision: lessons learned from mapping services for adults with Attention-Deficit/Hyperactivity Disorder (ADHD) in the UK.

Authors:  Anna Price; Astrid Janssens; Susan Dunn-Morua; Helen Eke; Philip Asherson; Tony Lloyd; Tamsin Ford
Journal:  BMC Health Serv Res       Date:  2019-07-09       Impact factor: 2.655

8.  Young people with attention deficit hyperactivity disorder in transition from child to adult services: a qualitative study of the experiences of general practitioners in the UK.

Authors:  Tamsin Newlove-Delgado; Sharon Blake; Tamsin Ford; Astrid Janssens
Journal:  BMC Fam Pract       Date:  2019-11-20       Impact factor: 2.497

9.  Resumption of attention-deficit hyperactivity disorder medication in early adulthood: findings from a UK primary care prescribing study.

Authors:  Tamsin Newlove-Delgado; Tamsin J Ford; Willie Hamilton; Astrid Janssens; Ken Stein; Obioha C Ukoumunne
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-04-04       Impact factor: 4.785

10.  Regional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorder.

Authors:  Anna Price; Tamsin Ford; Astrid Janssens; Andrew James Williams; Tamsin Newlove-Delgado
Journal:  BJPsych Open       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.